vs
Side-by-side financial comparison of Dominari Holdings Inc. (DOMH) and LIFECORE BIOMEDICAL, INC. \DE\ (LFCR). Click either name above to swap in a different company.
LIFECORE BIOMEDICAL, INC. \DE\ is the larger business by last-quarter revenue ($31.1M vs $30.1M, roughly 1.0× Dominari Holdings Inc.). LIFECORE BIOMEDICAL, INC. \DE\ runs the higher net margin — -32.1% vs -438.1%, a 406.0% gap on every dollar of revenue. On growth, Dominari Holdings Inc. posted the faster year-over-year revenue change (220.4% vs -4.5%). Over the past eight quarters, Dominari Holdings Inc.'s revenue compounded faster (369.1% CAGR vs -0.1%).
LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.
DOMH vs LFCR — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $30.1M | $31.1M |
| Net Profit | $-131.8M | $-10.0M |
| Gross Margin | — | 25.0% |
| Operating Margin | -8.9% | -9.9% |
| Net Margin | -438.1% | -32.1% |
| Revenue YoY | 220.4% | -4.5% |
| Net Profit YoY | -12426.2% | -52.0% |
| EPS (diluted) | $-6.94 | $-0.29 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $30.1M | — | ||
| Q3 25 | $50.8M | $31.1M | ||
| Q2 25 | $34.1M | — | ||
| Q1 25 | $8.1M | $35.2M | ||
| Q4 24 | $9.4M | $32.6M | ||
| Q3 24 | $4.0M | $24.7M | ||
| Q2 24 | $6.2M | — | ||
| Q1 24 | $1.4M | $35.7M |
| Q4 25 | $-131.8M | — | ||
| Q3 25 | $125.2M | $-10.0M | ||
| Q2 25 | $16.6M | — | ||
| Q1 25 | $-32.5M | $-14.8M | ||
| Q4 24 | $1.1M | $-6.6M | ||
| Q3 24 | $-4.2M | $-16.2M | ||
| Q2 24 | $-6.1M | — | ||
| Q1 24 | $-5.4M | $15.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | 25.0% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 28.0% | ||
| Q4 24 | — | 34.0% | ||
| Q3 24 | — | 21.8% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 33.3% |
| Q4 25 | -8.9% | — | ||
| Q3 25 | -3.1% | -9.9% | ||
| Q2 25 | -57.0% | — | ||
| Q1 25 | -394.6% | -25.7% | ||
| Q4 24 | 0.4% | -6.0% | ||
| Q3 24 | -79.1% | -46.9% | ||
| Q2 24 | -44.3% | — | ||
| Q1 24 | -205.2% | -2.5% |
| Q4 25 | -438.1% | — | ||
| Q3 25 | 246.4% | -32.1% | ||
| Q2 25 | 48.7% | — | ||
| Q1 25 | -400.5% | -42.0% | ||
| Q4 24 | 11.4% | -20.2% | ||
| Q3 24 | -104.2% | -65.7% | ||
| Q2 24 | -99.1% | — | ||
| Q1 24 | -398.0% | 43.8% |
| Q4 25 | $-6.94 | — | ||
| Q3 25 | $7.27 | $-0.29 | ||
| Q2 25 | $1.12 | — | ||
| Q1 25 | $-3.02 | $-0.47 | ||
| Q4 24 | $0.21 | $-0.25 | ||
| Q3 24 | $-0.67 | $-0.53 | ||
| Q2 24 | $-1.01 | — | ||
| Q1 24 | $-0.91 | $0.42 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $80.5M | $18.9M |
| Total DebtLower is stronger | — | $136.0M |
| Stockholders' EquityBook value | $69.4M | $-10.5M |
| Total Assets | $112.9M | $235.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $80.5M | — | ||
| Q3 25 | $176.2M | $18.9M | ||
| Q2 25 | $28.2M | — | ||
| Q1 25 | $18.9M | $5.4M | ||
| Q4 24 | $8.2M | $9.5M | ||
| Q3 24 | $7.2M | — | ||
| Q2 24 | $12.1M | — | ||
| Q1 24 | $7.1M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | $136.0M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $124.9M | ||
| Q4 24 | — | $111.3M | ||
| Q3 24 | — | $106.3M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $97.1M |
| Q4 25 | $69.4M | — | ||
| Q3 25 | $210.2M | $-10.5M | ||
| Q2 25 | $88.6M | — | ||
| Q1 25 | $42.4M | $2.2M | ||
| Q4 24 | $39.9M | $15.4M | ||
| Q3 24 | $38.3M | $-3.9M | ||
| Q2 24 | $42.4M | — | ||
| Q1 24 | $47.7M | $17.7M |
| Q4 25 | $112.9M | — | ||
| Q3 25 | $223.4M | $235.2M | ||
| Q2 25 | $109.3M | — | ||
| Q1 25 | $52.3M | $237.7M | ||
| Q4 24 | $47.1M | $255.4M | ||
| Q3 24 | $43.4M | $246.8M | ||
| Q2 24 | $49.1M | — | ||
| Q1 24 | $52.2M | $246.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 56.05× | ||
| Q4 24 | — | 7.20× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 5.49× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $22.7M | $1.8M |
| Free Cash FlowOCF − Capex | — | $25.0K |
| FCF MarginFCF / Revenue | — | 0.1% |
| Capex IntensityCapex / Revenue | — | 5.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-16.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $22.7M | — | ||
| Q3 25 | $-4.9M | $1.8M | ||
| Q2 25 | $-353.0K | — | ||
| Q1 25 | $1.2M | $1.2M | ||
| Q4 24 | $-16.7M | $-6.1M | ||
| Q3 24 | $-4.7M | $-613.0K | ||
| Q2 24 | $1.4M | — | ||
| Q1 24 | $-8.6M | $-1.4M |
| Q4 25 | — | — | ||
| Q3 25 | — | $25.0K | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $-4.3M | ||
| Q4 24 | — | $-8.6M | ||
| Q3 24 | — | $-4.0M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $-7.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -12.1% | ||
| Q4 24 | — | -26.3% | ||
| Q3 24 | — | -16.3% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -21.8% |
| Q4 25 | — | — | ||
| Q3 25 | — | 5.6% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 15.5% | ||
| Q4 24 | — | 7.5% | ||
| Q3 24 | — | 13.9% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 17.8% |
| Q4 25 | — | — | ||
| Q3 25 | -0.04× | — | ||
| Q2 25 | -0.02× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -15.65× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -0.09× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DOMH
| Chief Operating Decision Maker | $30.1M | 100% |
| Commissions | $458.0K | 2% |
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
